Meet Ipsen in the US

We seek to advance scientific and medical knowledge by funding certain types of requests for medical education that will benefit the public and improve patient health.

We are interested in providing educational funding within our therapeutic areas: oncology, neurosciences, and rare disease. This includes acromegaly, neuroendocrine tumors, carcinoid syndrome, pancreatic cancer, neuromuscular and movement disorders, severe primary IGF-1 deficiency (SPIGFD) and fibrodysplasia ossificans progressiva (FOP). Ipsen has a preference for programs that are supported by multiple organizations.

Grant requests may come from academic institutions, state or national medical associations or societies, disease foundations and associations, or other medical education providers. For academic institutions, the University Grants Office should apply for the grant, rather than an individual department or research group. Grants will not be given to individuals. Ipsen does not fund noneducational expenses.

Approval of grant funding is never related to or conditioned upon past prescriptions or purchases of Ipsen products. Ipsen does not offer or provide educational grants to encourage or to reward the prescription, purchase, order or recommendation of Ipsen products.

Ipsen supports independent research relating to our disease areas of interest to advance research and enhance disease understanding.

Investigator Sponsored Studies (ISS) investigators and/or their affiliated institutions take responsibility for the study as the Sponsor. The obligations of a sponsor-investigator include both those of a sponsor and those of an investigator. This means taking responsibility for all aspect of the study, including study:

• Design
• Regulatory approval
• Initiation
• Conduct
• Monitoring
• Reporting of safety data
• Analysis and publication of the results

Your ISS proposal will be reviewed by the Ipsen Medical Affairs Review Board for scientific merit as well as safety, legal, ethical and budgetary considerations. Support for endorsed proposals may be provided in the form of financial support and/or study drug supply pursuant to a written agreement which requires that you – as sponsor – comply with applicable local laws, rules, guidelines and regulations.

Through our charitable contribution efforts, Ipsen provides donations to 501 (c)(3) organizations located in the US that are aligned with our company social responsibility priorities and focus on 1) health and social service initiatives aimed at improving patients’ lives, especially in the areas of oncology, neuroscience and rare disease; 2) science, technology, engineering and mathematics or STEM education programs; 3) environment sustainability; and 4) initiatives that aim to strengthen and address critical needs in communities where our employees live and work.

Charitable contributions are reviewed and evaluated by the Charitable Funding Committee (CFC), a committee that meets quarterly or as needed. We accept online requests for charitable contributions from qualified 501 (c)(3) US-based organizations as outlined below and our typical donation amount is $5,000.

Approval of charitable contributions are never related to or conditioned upon past prescriptions or purchases of Ipsen products. Ipsen does not offer or provide charitable contributions to encourage or to reward the prescription, purchase, order or recommendation of Ipsen products.

Our mission is to have active inclusion and equity for all suppliers, whether small, large, or diverse.  By making supplier diversity a part of our business strategy, we can support the innovative talents of our workforce and marketplace for further growth and development.

Ipsen sources a broad range of commodities and services that vary based on location and business unit.  Below is a high-level list of goods and services we currently procure from suppliers:

Ipsen requires all suppliers to register within our tool to support our compliance with our supplier diversity program and to pave the way for a quick and efficient onboarding of your organization. Validation of a supplier’s diverse status is required for participation in Ipsen’s Supplier Diversity efforts.

For more information regarding our Supplier Diversity program, please contact supplier.diversity@ipsen.com. To register as a supplier, click here.

We believe that informed public policy plays an important role in improving patients’ lives. That’s why we work collaboratively with industry, academia, and policy groups, including the Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), the National Pharmaceutical Council (NPC), the Massachusetts Biotechnology Council, BioNJ, Innovative Medicines Canada, the Organization for International Investment, the European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and Associations, and more.